Benjamin Wolozin, M.D., Ph.D., selected to receive the Massachusetts Neuroscience Consortium Award
Congratulations to Benjamin Wolozin, M.D., Ph.D., who was selected to receive the Massachusetts Neuroscience Consortium Award for his proposal to identify the target(s) of action of the TDP-43 inclusion-inhibitory compounds that he has identified.
The Massachusetts Neuroscience Consortium, “is designed to accelerate pre-clinical research available to the pharmaceutical industry, introduce, academic researchers to the challenges of targeted research, and facilitate industry-academic partnerships.”
Dr. Wolozin is a professor in the Department of Pharmacology & Experimental Therapeutics and the Neurology, Principal Investigator of the Laboratory of Neurodegeneration and member of The Boston University Alzheimer’s Disease Center. For more information on Dr. Wolozin’s research, please visit his webpage here.
For more information on the Massachusetts Neuroscience Consortium Award, please visit Boston.com for their press release on the award.
Hat’s off to Dr. Wolozin!